Tema Neuroscience and Mental Health ETF (MNTL) Holdings $23.43 +0.55 (+2.40%) Closing price 05/2/2025 03:05 PM EasternExtended Trading$23.43 +0.00 (+0.00%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Top 48 MNTL HoldingsRankCompanyCurrent PriceWeightShares Held1VRTXVertex Pharmaceuticals$501.15+0.5%11.47%2,2982REGNRegeneron Pharmaceuticals$605.61+2.6%7.53%1,2843ARGXargenx$649.67+1.5%5.63%8904ALNYAlnylam Pharmaceuticals$259.39+1.7%5.11%1,9825LLYEli Lilly and Company$825.10+3.9%4.82%5476TEVATeva Pharmaceutical Industries$16.22+3.8%4.39%28,8617CRNXCrinetics Pharmaceuticals$33.76+0.7%4.28%13,0668NBIXNeurocrine Biosciences$109.68+2.9%4.12%3,9049BIIBBiogen$123.53+2.2%2.97%2,50110SYKStryker$378.60+1.2%2.92%798 Get the Latest News and Ratings for MNTL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tema Neuroscience and Mental Health ETF and its competitors with MarketBeat's FREE daily newsletter. 11CPRXCatalyst Pharmaceuticals$24.84+2.3%2.70%11,35212AXSMAxsome Therapeutics$112.210.0%2.56%2,32713IONSIonis Pharmaceuticals$32.78+3.4%2.50%8,31814DNLIDenali Therapeutics$16.44+2.4%2.48%15,17415MDTMedtronic$84.74+1.4%2.47%2,97616XENEXenon Pharmaceuticals$38.28+0.5%2.29%6,11117First American Treasury Obligations FundN/A2.22%226,04618UCB SAN/A2.13%1,19319JAZZJazz Pharmaceuticals$120.05+2.4%1.92%1,67220PENPenumbra$295.97+1.4%1.77%61721RNAAvidity Biosciences$32.20-1.5%1.73%5,39222ALKSAlkermes$31.78+3.9%1.67%5,94023OPCHOption Care Health$32.95+2.4%1.58%4,97524DXCMDexCom$81.62+16.2%1.56%2,23125SRRKScholar Rock$32.91+0.5%1.56%4,83626PTCTPTC Therapeutics$49.95+0.9%1.53%3,12427ACADACADIA Pharmaceuticals$14.91+2.3%1.52%10,59628Siemens Healthineers AGN/A1.31%2,49529SRPTSarepta Therapeutics$63.51+1.2%1.19%1,94330Sysmex CorporationN/A1.11%6,10831IMVTImmunovant$15.80-0.6%0.93%5,86632Orion OyjN/A0.88%1,44033DAWNDay One Biopharmaceuticals$7.93+4.1%0.86%11,30534TALKTalkspace$3.19+1.9%0.84%27,83435BHVNBiohaven$22.76+1.4%0.83%3,83136NTLAIntellia Therapeutics$8.84+2.3%0.67%7,67737ACHCAcadia Healthcare$23.31+2.3%0.60%2,59638Eisai Co., Ltd.N/A0.57%2,03639PRTAProthena$8.50-2.5%0.57%6,35140DYNDyne Therapeutics$11.86-1.1%0.54%4,717Trump’s Bitcoin Reserve is No Accident… (Ad)Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new blockchain development…Just click here to get all the details on this crypto coin now41VYGRVoyager Therapeutics$3.64+2.5%0.52%14,96042PRAXPraxis Precision Medicines$40.24+5.7%0.39%1,05543SLDBSolid Biosciences$4.31+18.1%0.28%8,64944ARVNArvinas$7.72+6.8%0.20%2,07445RAPPRapport Therapeutics$11.33-1.2%0.17%1,49946EURON/A0.11%10,24447JAPANESE YENN/A0.03%425,87448DEPOSITS WITH BROKER FOR SHORT POSITIONSN/A-0.02%24,779,302 Geographic ExposureUnited States82.6%Ireland6.8%Canada2.3%Belgium2.2%Japan1.7%Germany1.3%Finland0.9%Virgin Islands, British0.9%Currency ExposureUSD93.8%EUR4.5%JPY1.7%Sector ExposureHealth Care96.7%Industry ExposureBiotechnology80.4%Health Care Equipment & Supplies11.2%Health Care Providers & Services3.0%Pharmaceuticals2.1%SubIndustry ExposureBiotechnology72.0%Health Care Equipment10.1%Pharmaceuticals4.7%Health Care Services2.5%Life Sciences Tools & Services1.1%Health Care Facilities0.6%Coupon Exposure4-62.2%Maturity Exposure15-202.2% Related Companies and Tools Related Companies DYNI Holdings AQWA Holdings EQRR Holdings GXTG Holdings FIVY Holdings GXDW Holdings SPCX Holdings TMET Holdings ESMV Holdings COPJ Holdings This page (NASDAQ:MNTL) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tema Neuroscience and Mental Health ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Tema Neuroscience and Mental Health ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.